查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1662624

2030 年腸外營養市場預測：按產品類型、營養類型、給藥途徑、應用、最終用戶和地區進行的全球分析

Parenteral Nutrition Market Forecasts to 2030 - Global Analysis By Product Type (Total Parenteral Nutrition (TPN) and Partial Parenteral Nutrition (PPN)), Nutrient Type, Route of Administration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球腸外營養市場價值為 75 億美元，預計到 2030 年將達到 114 億美元，預測期內的複合年成長率為 7.0%。

腸外營養（PN）是一種繞過消化器官系統將必需營養素直接輸送到血液的治療方法。它通常用於因胃腸道疾病、手術或嚴重營養不良等情況而無法從正常飲食中吸收營養的患者。 PN 透過靜脈注射提供客製化的碳水化合物、蛋白質、脂質、維生素和礦物質混合物，以確保患者獲得足夠的營養來恢復和維持身體功能。根據患者的需要，可以提供短期或長期的營養支持。

根據美國疾病管制與預防中心（ 美國）的數據，2022 年全國早產率約為 10.4%。同一時期，非裔美國女性的早產率約為 14.6%。

慢性病盛行率上升

癌症、糖尿病和胃腸道疾病等慢性病的發生率上升正在推動市場的成長。這些疾病通常會損害營養吸收，需要靜脈營養支持。隨著越來越多的患者需要客製化的營養補充來控制營養不良和康復，對腸外營養解決方案的需求正在成長。這一趨勢正在推動配方創新並擴大市場以改善患者的治療效果。

報銷範圍有限

腸外營養的保險報銷有限是一個重大的市場挑戰，限制了許多需要長期營養支持的患者獲得營養支持。保險報銷不足會導致高昂的自付費用，使治療成為經濟負擔。這限制了獲得基本護理的機會，尤其是對於患有慢性病的患者和居家醫療的患者。由於缺乏足夠的保險覆蓋，導致治療延遲，對患者的治療結果產生負面影響。

居家醫療需求不斷增加

居家醫療需求的不斷成長促進了市場的擴大。需要長期營養支持的患者擴大在家中接受護理，從而減少了住院時間和醫療費用。可攜式輸液幫浦和改良劑型等家庭用藥的進步使得病人用藥更加安全方便。這種向居家醫療的轉變加速了慢性病患者採用腸外營養。

腸外營養成本高昂

腸外營養 (PN) 的高成本是其廣泛應用的重大障礙，尤其是對於保險不足的患者而言。治療費用高昂，包括專門的配方、設備和醫療支持，給患者和醫療保健系統帶來了經濟負擔。這可能會導致獲得醫療護理的延遲或限制，特別是對於低收入人群，最終影響患者的治療結果並擴大醫療保健差距。

COVID-19 的影響

COVID-19 疫情對市場產生了重大影響，由於 COVID-19 患者的嚴重營養不良和胃腸道併發症增加，需求增加。隨著醫療保健系統將重點轉向重症加護，醫院變得不堪重負，對家庭 PN 的需求也隨之增加。然而，供應鏈中斷和關鍵原料的短缺最初影響了可得性。儘管有這些挑戰，疫情加速了採用居家醫療解決方案來提供長期營養支持。

預計預測期內氨基酸部分將以最快的速度成長。

預計預測期內胺基酸部分將佔據最大的市場佔有率，因為胺基酸是蛋白質合成和整體身體功能的必需成分。在配方中，胺基酸透過靜脈注射來支持無法口服吸收營養的患者。客製化胺基酸解決方案可根據個人的特定需求，特別是患有慢性疾病的人的特定需求而量身定做，以確保適當的恢復，維持肌肉質量並防止營養不良。

預計預測期內醫院部門將以最高的複合年成長率成長。

預計預測期內醫院部門將呈現最高的成長率。醫院是向嚴重營養不良、胃腸道疾病患者以及手術後康復患者提供藥物的主要場所。在醫院裡，使用特殊製劑來滿足無法口服吸收營養的重症患者的營養需求。需要營養支持的慢性和複雜疾病的發生率不斷上升，並持續推動醫院的需求。

比最大的地區

在預測期內，由於慢性病盛行率上升、人口老化以及對居家醫療解決方案的需求不斷增加，預計北美將佔據最大的市場佔有率。該地區先進的醫療基礎設施以及 PN 配方和給藥方法的創新進一步推動了市場擴張。此外，強力的報銷政策和對改善患者治療效果的關注也促進了該地區的採用率不斷提高。

複合年成長率最高的地區

預計預測期內亞太地區將呈現最高的複合年成長率。隨著診斷工具的改進和對營養在各種醫療狀況管理中的重要性的理解不斷加深，醫療保健行業對腸外營養的認知也日益加深。此外，該地區的一些政府正致力於改善醫療保健和營養的機會，特別是在開發中國家。這為市場成長創造了有利的環境。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 介紹
  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球腸外營養市場依產品類型分類

  • 介紹
  • 全靜脈營養（TPN）
  • 部分腸外營養 (PPN)

6. 全球腸外營養市場依營養類型分類

  • 介紹
  • 胺基酸
  • 碳水化合物
  • 脂質
  • 維生素和礦物質
  • 微量元素

7. 全球腸外營養市場依給藥途徑分類

  • 介紹
  • 完全腸外營養（CPN）
  • 周邊靜脈營養（PPN）

8. 全球腸外營養市場（依應用）

  • 介紹
  • 癌症
  • 胃腸道疾病
  • 神經系統疾病
  • 加護治療
  • 小兒科/新生兒
  • 肝臟疾病
  • 其他

9. 全球腸外營養市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 居家醫療
  • 長期照護機構
  • 其他

第 10 章。

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • AbbVie Inc.
  • Baxter International Inc.
  • Merck & Co.
  • Danone Nutricia
  • Medi Pharma
  • Eli Lilly and Company
  • Aptalis Pharma
  • Sodium Bicarbonate LLC
  • Biomarin Pharmaceutical
  • B. Braun Melsungen AG
  • Smith & Nephew
  • Roche Holding AG
  • Novartis International AG
  • Medtronic
  • Orion Corporation
Product Code: SMRC28485

According to Stratistics MRC, the Global Parenteral Nutrition Market is accounted for $7.5 billion in 2024 and is expected to reach $11.4 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Parenteral nutrition (PN) is a medical treatment that provides essential nutrients directly into the bloodstream, bypassing the digestive system. This is typically used for patients who cannot absorb nutrients through normal eating due to conditions like gastrointestinal disorders, surgeries, or severe malnutrition. PN delivers a customized mixture of carbohydrates, proteins, fats, vitamins, and minerals through an intravenous line, ensuring the patient receives adequate nutrition for recovery and maintenance of body functions. It can be short-term or long-term depending on the patient's needs.

According to the U.S. Centers for Disease Control and Prevention (CDC), the preterm birth rate in the country was approximately 10.4% in 2022. In addition, during the same period, the preterm birth rate for African American women was around 14.6%.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, diabetes, and gastrointestinal disorders, is driving the growth of the market. These conditions often impair nutrient absorption, necessitating intravenous nutrient support. As more patients require tailored nutrition to manage malnutrition and recovery, the demand for parenteral nutrition solutions increases. This trend is prompting innovations in the formulations and improving patient outcomes, thus expanding the market.

Restraint:

Limited reimbursement coverage

Limited reimbursement coverage for parenteral nutrition presents a significant challenge in the market, hindering access for many patients who need long-term nutritional support. Insufficient insurance reimbursement can lead to high out-of-pocket costs, making the treatment financially burdensome. This restricts patient access to essential care, particularly for those with chronic illnesses or in home healthcare settings. Consequently, the lack of adequate coverage can delay treatment and negatively impact patient outcomes.

Opportunity:

Growing demand for home healthcare

The growing demand for home healthcare is contributing to the expansion of the market. Patients requiring long-term nutritional support are increasingly being treated at home, reducing hospital stays and healthcare costs. Advances in home administration, including portable infusion pumps and improved formulations, are making it safer and more convenient for patients. This shift toward home healthcare is driving greater adoption of parenteral nutrition among individuals with chronic conditions.

Threat:

High cost of parenteral nutrition

The high cost of parenteral nutrition (PN) poses a significant barrier to its widespread adoption, particularly for patients without adequate insurance coverage. The expensive nature of the treatments, including specialized formulas, equipment, and healthcare support, can lead to financial strain on patients and healthcare systems. This can result in delayed treatments or limited access, especially in low-income populations, ultimately affecting patient outcomes and increasing healthcare disparities.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market, increasing demand due to the rise in severe malnutrition and gastrointestinal complications among COVID-19 patients. The healthcare system's focus on critical care further heightened the need for home-based PN as hospitals were overwhelmed. However, disruptions in supply chains and shortages of key ingredients initially affected availability. Despite these challenges, the pandemic accelerated the adoption of home healthcare solutions for long-term nutritional support.

The amino acids segment is expected to be the largest during the forecast period

The amino acids segment is expected to account for the largest market share during the forecast period as they are essential building blocks for protein synthesis and overall body function. In formulations, amino acids are provided intravenously to support patients who cannot absorb nutrients orally. Customized amino acid solutions are tailored to meet the specific needs of individuals, especially those with chronic conditions, ensuring proper recovery, maintaining muscle mass, and preventing malnutrition.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate as they are primary settings for administering to patients with severe malnutrition, gastrointestinal disorders, or recovery from surgeries. Hospitals use specialized formulations to meet the nutritional needs of critically ill patients who cannot absorb nutrients orally. The demand in hospitals continues to grow due to the increasing prevalence of chronic diseases and complex medical conditions requiring nutritional support.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by the rising prevalence of chronic diseases, an aging population, and increasing demand for home healthcare solutions. The region's advanced healthcare infrastructure, along with innovations in PN formulations and delivery methods, further fuels market expansion. Additionally, strong reimbursement policies and a focus on improving patient outcomes are contributing to the growing adoption in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. There is growing awareness of parenteral nutrition in the healthcare community, with better diagnostic tools and a rising understanding of the importance of nutrition in managing various medical conditions. Additionally, several governments in the region are focusing on improving healthcare access and nutrition, especially in developing countries. This creates a conducive environment for the growth of the market.

Key players in the market

Some of the key players in Parenteral Nutrition market include AbbVie Inc., Baxter International Inc., Merck & Co., Danone Nutricia, Medi Pharma, Eli Lilly and Company, Aptalis Pharma, Sodium Bicarbonate LLC, Biomarin Pharmaceutical, B. Braun Melsungen AG, Smith & Nephew, Roche Holding AG, Novartis International AG, Medtronic and Orion Corporation.

Key Developments:

In June 2024, AbbVie and FutureGen Biopharmaceutical (Beijing) Co., Ltd. announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

In May 2024, Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates.

Product Types Covered:

  • Total Parenteral Nutrition (TPN)
  • Partial Parenteral Nutrition (PPN)

Nutrient Types Covered:

  • Amino Acids
  • Carbohydrates
  • Lipids
  • Vitamins & Minerals
  • Trace Elements

Route of Administrations Covered:

  • Central Parenteral Nutrition (CPN)
  • Peripheral Parenteral Nutrition (PPN)

Applications Covered:

  • Cancer
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Critical Care
  • Pediatrics/Neonates
  • Liver Disease
  • Other Applications

End Users Covered:

  • Hospitals
  • Homecare
  • Long-Term Care Facilities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Parenteral Nutrition Market, By Product Type

  • 5.1 Introduction
  • 5.2 Total Parenteral Nutrition (TPN)
  • 5.3 Partial Parenteral Nutrition (PPN)

6 Global Parenteral Nutrition Market, By Nutrient Type

  • 6.1 Introduction
  • 6.2 Amino Acids
  • 6.3 Carbohydrates
  • 6.4 Lipids
  • 6.5 Vitamins & Minerals
  • 6.6 Trace Elements

7 Global Parenteral Nutrition Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Central Parenteral Nutrition (CPN)
  • 7.3 Peripheral Parenteral Nutrition (PPN)

8 Global Parenteral Nutrition Market, By Application

  • 8.1 Introduction
  • 8.2 Cancer
  • 8.3 Gastrointestinal Disorders
  • 8.4 Neurological Disorders
  • 8.5 Critical Care
  • 8.6 Pediatrics/Neonates
  • 8.7 Liver Disease
  • 8.8 Other Applications

9 Global Parenteral Nutrition Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Homecare
  • 9.4 Long-Term Care Facilities
  • 9.5 Other End Users

10 Global Parenteral Nutrition Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 AbbVie Inc.
  • 12.2 Baxter International Inc.
  • 12.3 Merck & Co.
  • 12.4 Danone Nutricia
  • 12.5 Medi Pharma
  • 12.6 Eli Lilly and Company
  • 12.7 Aptalis Pharma
  • 12.8 Sodium Bicarbonate LLC
  • 12.9 Biomarin Pharmaceutical
  • 12.10 B. Braun Melsungen AG
  • 12.11 Smith & Nephew
  • 12.12 Roche Holding AG
  • 12.13 Novartis International AG
  • 12.14 Medtronic
  • 12.15 Orion Corporation

List of Tables

  • Table 1 Global Parenteral Nutrition Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Parenteral Nutrition Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Parenteral Nutrition Market Outlook, By Total Parenteral Nutrition (TPN) (2022-2030) ($MN)
  • Table 4 Global Parenteral Nutrition Market Outlook, By Partial Parenteral Nutrition (PPN) (2022-2030) ($MN)
  • Table 5 Global Parenteral Nutrition Market Outlook, By Nutrient Type (2022-2030) ($MN)
  • Table 6 Global Parenteral Nutrition Market Outlook, By Amino Acids (2022-2030) ($MN)
  • Table 7 Global Parenteral Nutrition Market Outlook, By Carbohydrates (2022-2030) ($MN)
  • Table 8 Global Parenteral Nutrition Market Outlook, By Lipids (2022-2030) ($MN)
  • Table 9 Global Parenteral Nutrition Market Outlook, By Vitamins & Minerals (2022-2030) ($MN)
  • Table 10 Global Parenteral Nutrition Market Outlook, By Trace Elements (2022-2030) ($MN)
  • Table 11 Global Parenteral Nutrition Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 12 Global Parenteral Nutrition Market Outlook, By Central Parenteral Nutrition (CPN) (2022-2030) ($MN)
  • Table 13 Global Parenteral Nutrition Market Outlook, By Peripheral Parenteral Nutrition (PPN) (2022-2030) ($MN)
  • Table 14 Global Parenteral Nutrition Market Outlook, By Application (2022-2030) ($MN)
  • Table 15 Global Parenteral Nutrition Market Outlook, By Cancer (2022-2030) ($MN)
  • Table 16 Global Parenteral Nutrition Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
  • Table 17 Global Parenteral Nutrition Market Outlook, By Neurological Disorders (2022-2030) ($MN)
  • Table 18 Global Parenteral Nutrition Market Outlook, By Critical Care (2022-2030) ($MN)
  • Table 19 Global Parenteral Nutrition Market Outlook, By Pediatrics/Neonates (2022-2030) ($MN)
  • Table 20 Global Parenteral Nutrition Market Outlook, By Liver Disease (2022-2030) ($MN)
  • Table 21 Global Parenteral Nutrition Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 22 Global Parenteral Nutrition Market Outlook, By End User (2022-2030) ($MN)
  • Table 23 Global Parenteral Nutrition Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Parenteral Nutrition Market Outlook, By Homecare (2022-2030) ($MN)
  • Table 25 Global Parenteral Nutrition Market Outlook, By Long-Term Care Facilities (2022-2030) ($MN)
  • Table 26 Global Parenteral Nutrition Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.